Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review

Converting Enzyme ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽

Response to the Letter to the Editor From Dr Kawada, “Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus”

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.08.004 ◽

2020 ◽

Vol 44 (1) ◽

pp. 5

Author(s):

Thomas A. Mavrakanas ◽

Mark L. Lipman

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2019.01.001 ◽

2020 ◽

Vol 44 (1) ◽

pp. 4 ◽

Cited By ~ 1

Author(s):

Tomoyuki Kawada

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Impact of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria

Diabetic Medicine ◽

10.1111/dme.14107 ◽

2019 ◽

Vol 37 (1) ◽

pp. 44-52 ◽

Cited By ~ 1

Author(s):

C. I. Coleman ◽

E. R. Weeda ◽

A. Kharat ◽

B. Bookhart ◽

W. L. Baker

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Effect of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers on the Prevention of Death in Patients with Type 2 Diabetes and Undetermined Nephropathy : Five-Year Survival Data

Journal of Diabetes & Metabolism ◽

10.4172/2155-6156.1000188 ◽

2012 ◽

Vol 03 (04) ◽

Author(s):

Sirima Mongkolsomlit ◽

Petch Rawdaree ◽

Chulalux Komoltri

Keyword(s):

Type 2 Diabetes ◽

Survival Data ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

A Propensity-Matched Study of the Comparative Effectiveness of Angiotensin Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Heart Failure Patients Age ≥65 Years

The American Journal of Cardiology ◽

10.1016/j.amjcard.2011.06.066 ◽

2011 ◽

Vol 108 (10) ◽

pp. 1443-1448 ◽

Cited By ~ 7

Author(s):

Yan Zhang ◽

Gregg C. Fonarow ◽

Paul W. Sanders ◽

Firoozeh Farahmand ◽

Richard M. Allman ◽

...

Keyword(s):

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Heart Failure Patients ◽

Receptor Blockers ◽

Matched Study

Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes

Current Hypertension Reports ◽

10.1007/s11906-002-0005-6 ◽

2002 ◽

Vol 4 (3) ◽

pp. 185-190 ◽

Cited By ~ 12

Author(s):

Jay Garg ◽

George L. Bakris

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Incidence of New Stroke or New Myocardial Infarction or Death at 39-Month Follow Up in Patients With Diabetes Mellitus, Hypertension, or Both Treated With and Without Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers

American Journal of Therapeutics ◽

10.1097/mjt.0b013e31804d1b53 ◽

2009 ◽

Vol 16 (1) ◽

pp. 2-4 ◽

Cited By ~ 2

Author(s):

Gautham Ravipati ◽

Wilbert S Aronow ◽

Chul Ahn ◽

Rose M Alappat ◽

John A McClung ◽

...

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Patients With Diabetes ◽

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2005.05.051 ◽

2005 ◽

Vol 46 (5) ◽

pp. 821-826 ◽

Cited By ~ 298

Author(s):

Hussam Abuissa ◽

Philip G. Jones ◽

Steven P. Marso ◽

James H. O’Keefe

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

1150-P: Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Renal Outcomes in Patients with Type 2 Diabetes and Proteinuria

Diabetes ◽

10.2337/db19-1150-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1150-P

Author(s):

CRAIG I. COLEMAN ◽

ERIN R. WEEDA ◽

AKSHAY A. KHARAT ◽

BRAHIM BOOKHART ◽

WILLIAM L. BAKER

Keyword(s):

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-analysis of Randomized Clinical Trials

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70292-0 ◽

2006 ◽

Vol 2006 ◽

pp. 73-74

Author(s):

J.L. Leahy

Keyword(s):

Randomized Clinical Trials ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Receptor ◽